Currently, both tumor- (e.g., alpha fetal protein (AFP), tumor size and portal vein thrombosis) and cirrhosis-based (mainly, the Child–Pugh class) parameters are commonly employed to predict patient survival [4]. This evidence concerns the gene AFP and neoplasm.